Clinical Trial Update: Anfibatide Phase Ib-IIa Clinical Trial [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib-IIa clinical trial of anfibatide for non-ST segment elevation myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-segment Elevation Myocardial Infarction

Drugs mentioned

• Anfibatide (anfibatide)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Non-ST Segment Elevation Myocardial Infarction | Phase 1, Phase 2 | Status: COMPLETED